media – Page 522 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Imutex Universal FLU Vaccine Reaching Phase 3

In phase 2b clinical trial work, FLU-v met its goal of boosting T-cell immune response at 42 days and 180 days after vaccination. The infection rate came down by meeting a secondary endpoint of boosting antibodies in vaccinated patients. Thus, this single adjuvant dose is considered as the "most immunological and efficient."
- Source: FiercePharma
- 902
- June 21, 2018
Clinical Trials flu influenza vaccine
FDA Approval for AI Enabled Diabetes Software

The Food and Drug Administration (FDA) has granted approval for a request made by DreaMed regarding their artificial intelligence-enabled diabetic software, which is exclusively meant for the providers, who are managing Type 1 diabetes patients.
- Source: MobiHealthNews
- 869
- June 20, 2018
AI digital health FDA New Approvals type 1 diabetes
Salmonella Warning for Cut Melons

Fresh cut melons sold at popular grocery stores were responsible for nearly 60 people being infected with Salmonella. In order to be sure of what is safe to consume and what not, refer to the list of Food and Drug Administration (FDA) consumable items. Here they state that people need not give up melons entirely but rather only the pre-cut ones.
- Source: HealthLine
- 559
- June 20, 2018
Researches Salmonella
Vertex Pharma Doubles Cystic Fibrosis Research Facility

Boston-based Vertex Pharmaceuticals has more than doubled their research facility in San Diego where they first discovered their key Cystic Fibrosis Drug adding more than 90000 sq ft. to it. The total facility will be now 170,000 sq. ft improving the pharma giant's capability to achieve the next generation of blockbusters.
- Source: Fierce Biotech
- 614
- June 20, 2018
biotech Company Insights
Syncona Once More Proves Commitment to Freeline in Series B Funding Round

Syncona has once again proven its commitment to gene therapy start-up, Freeline Therapeutics with a £85 million investment from the £88 million series B funding round. Freeline’s main focus is on gene therapy for Haemophilia B and Farby disease and this latest cash injection ensures Syncosa’s majority stake in the startup.
- Source: Fierce Biotech
- 660
- June 20, 2018
biotech Company Insight funding hemophilia
Antibiotic-free Chicken by 2022 – Pizza Hut

In a necessary effort to help curb the antibiotic-resistance issue, Pizza Hut’s efforts to extend the human-relevant antibiotic-free chicken from only their pizzas to all their chicken products, must be praised even though KFC has committed to achieving the same goal by the end of this year.
- Source: The Verge
- 591
- June 20, 2018
antibiotic resistance Policies
RapidSOS and Apple Partner to Help with Emergency Location Identification

In 2015, Apple initiated HELO (Hybridized Emergency Location) a protocol that helps identify a callers’ location using various data such as wifi access points, GPS and cell phone towers. This has now been further developed by RapidSOS to send the data via secure channels to emergency call rooms.
- Source: drugdu
- 637
- June 20, 2018
Apple Company Insight digital health
Identification of Asthma Causative Agent – Rhinovirus

The rhinovirus, otherwise known as the cold virus, is considered as the causative agent of asthma. Nearly 80% of all asthma attacks are caused by this cold virus, of which children are mostly affected. This viral asthma leads to chronic lung disease which in turn could be life-threatening.
- Source: India Times
- 861
- June 20, 2018
asthma cold virus Researches
‘Gaming Disorder’ Classified as Mental Disorder by WHO

The World Health Organization (WHO) has included ‘gaming disorder’ as a serious mental health condition in its International Classification of Diseases (ICD). Gaming disorder is officially considered to be serious since excessive priority is given to gaming over other everyday activities.
- Source: IndiaTimes
- 987
- June 20, 2018
Mental health Policies WHO
Ddu to Attend CPhI in Shanghai Sharing Insights on International Marketing of the Medical Trade

As China's leading event for the pharmaceutical industry, CPhI China strives to provide a platform for local, regional and international buyers, manufacturers and suppliers to meet, do business and drive research and development in the Chinese pharmaceutical and healthcare industries.
- Source: Ddu
- 2,987
- June 19, 2018
China CPhI Exhibitions and Activities

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.